References
Fink K, Grandvaux N. STAT2 and IRF9: beyond ISGF3. JAK–STAT. 2013;2(4):e27521. https://doi.org/10.4161/jkst.27521.
Fu XY, Schindler C, Improta T, et al. The proteins of ISGF-3, the interferon alpha-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci. 1992;89:7840–3.
Hambleton S, Goodbourn S, Young D, et al. STAT2 deficiency and susceptibility to viral illness in humans. Proc Natl Acad Sci. 2013;110(8):3053–8.
Platanias L. Mechanisms of type-I-and type-II-interferon-mediated signaling. Nat Rev Immunol. 2005;5:375–86.
Shahni R, Cale C, Anderson G, et al. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain. 2015;138:2834–46.
Takaoka K, Yanai H. Interferon signaling network in innate defence. Cell Microbiol. 2006;8(6):907–22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this entry
Cite this entry
Roberts, H., Turvey, S.E. (2018). Predisposition to Severe Viral Infection, STAT2 Deficiency. In: MacKay, I., Rose, N. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9209-2_52-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9209-2_52-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9209-2
Online ISBN: 978-1-4614-9209-2
eBook Packages: Springer Reference MedicineReference Module Medicine